Ticker >

Nath Bio-Genes share price

Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN BSE: 537291 SECTOR: Agriculture  42k   131   10

190.75
-5.10 (-2.60%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 199.25

Today's Low

₹ 190

52 Week High

₹ 243.7

52 Week Low

₹ 160.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

362.5 Cr.

Enterprise Value

429.73 Cr.

No. of Shares

1.9 Cr.

P/E

9.87

P/B

0.59

Face Value

₹ 10

Div. Yield

1.05 %

Book Value (TTM)

₹  321.33

CASH

37.98 Cr.

DEBT

105.21 Cr.

Promoter Holding

45.6 %

EPS (TTM)

₹  19.33

Sales Growth

8.24%

ROE

6.31 %

ROCE

7.09%

Profit Growth

152.22 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.24%
3 Year2.49%
5 Year9.47%

Profit Growth

1 Year152.22%
3 Year-11.36%
5 Year3.63%

ROE%

1 Year6.31%
3 Year1.39%
5 Year4.3%

ROCE %

1 Year7.09%
3 Year3.02%
5 Year5.31%

Debt/Equity

0.1835

Price to Cash Flow

9.45

Interest Cover Ratio

4.55605600704984

CFO/PAT (5 Yr. Avg.)

0.383184852493632

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 45.6 16.38
Dec 2023 45.6 16.38
Sep 2023 45.6 16.38
Jun 2023 45.6 16.38
Mar 2023 45.6 16.38
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.0648386838168466.
  • The company has an efficient Cash Conversion Cycle of -374.158712910884 days.
  • Company has a healthy liquidity position with current ratio of 2.40722027932447.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 14.5891186544305.

 Limitations

  • The company has shown a poor profit growth of -11.3553341560401% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.48637363422617% for the Past 3 years.
  • Company has a poor ROE of 1.38519309579305% over the past 3 years.
  • Company has a poor ROCE of 3.01525764850281% over the past 3 years
  • Tax rate is low at 3.1744589459772.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 44.92 235.28 22.57 31.74 43.04
Total Expenditure 40.83 198.25 17.05 25.95 38.56
Operating Profit 4.08 37.03 5.52 5.78 4.48
Other Income 0.26 0.12 0.06 0.04 0.44
Interest 1.53 2.77 2.44 2.84 1.06
Depreciation 0.99 0.76 0.76 0.76 0.98
Exceptional Items 0 0 0 2.5 0
Profit Before Tax 1.82 33.62 2.38 4.72 2.87
Tax 0.23 0.22 0.35 0.77 0.62
Profit After Tax 1.59 33.4 2.04 3.96 2.26
Adjusted EPS (Rs) 0.84 17.58 1.07 2.08 1.19

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 230.93 279.89 307.56 278.36 301.29
Total Expenditure 187.56 225.1 240.8 241.09 252.31
Operating Profit 43.37 54.79 66.76 37.27 48.98
Other Income 2.27 1.82 1.67 1.85 0.56
Interest 5.33 6.65 8.87 10.64 10.21
Depreciation 1.45 1.45 2.82 3.08 3.01
Exceptional Items 0 0 0 -88.78 0
Profit Before Tax 38.87 48.51 56.75 -63.39 36.32
Tax 0.43 -1.98 1.09 3.95 1.15
Net Profit 38.43 50.48 55.66 -67.34 35.17
Adjusted EPS (Rs.) 20.22 26.57 29.29 -35.43 18.5

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 19 19 19 19 19
Total Reserves 488.58 538.61 594.27 522.97 554.35
Borrowings 0.5 0.3 0.65 0.66 0.4
Other N/C liabilities 1.16 1.72 2.57 2.61 2.79
Current liabilities 138.68 169.62 173 194.29 216.43
Total Liabilities 647.93 729.25 789.51 739.54 792.97
Assets
Net Block 231.72 246.03 246.93 244.89 244.38
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 5 5 5.05 5.06 5.06
Loans & Advances 1.43 5.89 1.44 21.79 22.54
Other N/C Assets 0.02 0 0 0 0
Current Assets 409.77 472.33 536.1 467.8 520.99
Total Assets 647.93 729.25 789.51 739.54 792.97
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 38.87 48.51 56.75 -63.39 36.32
Adjustment 4.56 6.99 9.79 102.29 12.93
Changes in Assets & Liabilities -63.64 -44.5 -65.13 -18.97 -9.97
Tax Paid -2.72 -1.52 -0.3 -2.88 -0.92
Operating Cash Flow -22.94 9.48 1.11 17.05 38.37
Investing Cash Flow -20.48 -14.44 -10.28 -19.87 -2.88
Financing Cash Flow 20.14 5.56 16.4 -22.23 -1.67
Net Cash Flow -23.28 0.61 7.23 -25.05 33.82

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 45.60 45.60 45.60 45.60 45.60
akash farms llp 7.95 7.95 7.95 9.59 12.24
arati farms private limit... 1.07 1.07 1.07 1.07 1.07
ashu farms llp 10.99 10.99 10.99 13.68 13.68
barkha farms llp - - - 2.75 2.75
emerald seeds private lim... 3.63 3.63 3.63 3.63 3.63
ferry fax farms private l... 1.62 1.62 1.62 1.62 1.62
nath biotechnologies ltd 0.53 0.53 0.53 0.53 0.53
nath industries limited 2.80 2.80 2.80 2.80 2.80
nath royal ltd 2.60 2.60 2.60 2.60 2.60
pithambar farms private l... 1.32 1.32 1.32 1.32 1.32
prabha farms private limi... 0.40 0.40 0.40 0.40 0.40
tingli finvest pvt ltd 2.96 2.96 2.96 2.96 2.96
agri tech india limited 7.87 7.87 7.87 2.65 -
barkha farms private limi... 1.86 1.86 1.86 - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 54.40 54.40 54.40 54.40 54.40
aditya birla sun life tru... 4.61 4.61 4.36 4.36 4.36
mayo farms llp 5.72 5.72 5.72 5.72 5.72
meghal bakulesh shah - - - - 1.31
satpal khattar 2.10 2.10 2.10 2.10 2.10
tapovan farms llp 5.18 5.18 5.18 5.18 5.18
kbs properties private li... 1.62 1.62 1.62 1.62 -
seetha kumari - 1.43 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Nath Bio-Genes - Quaterly Results8 May 2024, 5:19PM Nath Bio-Genes - Quaterly Results8 May 2024, 5:19PM Nath Bio-Genes - Quaterly Results8 May 2024, 5:19PM Nath Bio-Genes (India) informs about compliances-certificate 15 Apr 2024, 2:30PM Nath Bio-Genes (India) informs about EGM15 Mar 2024, 2:52PM Nath Bio-Genes (India) informs about disclosure22 Feb 2024, 2:21PM Nath Bio-Genes - Quaterly Results18 Jan 2024, 6:27PM Nath Bio-Genes - Quaterly Results18 Jan 2024, 6:27PM Nath Bio-Genes (India) informs about disclosure22 Dec 2023, 10:51AM Nath Bio-Genes (India) informs about disclosure12 Dec 2023, 5:13PM Nath Bio-Genes (India) informs about conference call21 Oct 2023, 10:33AM Nath Bio-Genes - Quaterly Results16 Oct 2023, 6:09PM Nath Bio-Genes - Quaterly Results16 Oct 2023, 6:09PM Nath Bio-Genes - Quaterly Results10 Aug 2023, 5:41PM Nath Bio-Genes - Quaterly Results10 Aug 2023, 5:41PM Nath Bio-Genes (India) informs about AGM17 Jun 2023, 3:58PM Nath Bio-Genes (India) informs about change in date of AGM and book closure 23 May 2023, 2:36PM Nath Bio-Genes - Quaterly Results22 Apr 2023, 5:58PM Nath Bio-Genes - Quaterly Results22 Apr 2023, 5:58PM Nath Bio-Genes (India) informs about compliance certificate17 Apr 2023, 2:36PM Nath Bio-Genes (India) informs about analyst meet6 Dec 2022, 3:17PM Nath Bio-Genes (India) informs about loss of share certificate 24 Nov 2022, 4:27PM Nath Bio-Genes - Quaterly Results20 Oct 2022, 3:43PM Nath Bio-Genes - Quaterly Results20 Oct 2022, 3:43PM Nath Bio-Genes - Quaterly Results20 Oct 2022, 3:43PM Nath Bio-Genes (India) informs about disclosure 3 Sep 2022, 11:20AM Nath Bio-Genes (India) informs about disclosure29 Aug 2022, 4:47PM Nath Bio-Genes (India) informs about compliance certificate27 Jul 2022, 11:58AM Nath Bio-Genes (India) informs about disclosure24 Jun 2022, 9:51AM Nath Bio-Genes - Quaterly Results11 Feb 2022, 4:17PM Nath Bio-Genes (India) board to approve financial results 4 Feb 2022, 5:09PM Nath Bio-Genes - Quaterly Results1 Nov 2021, 4:24PM Nath Bio-Genes (India) informs about board meeting25 Oct 2021, 12:58PM Nath Bio-Genes (India) informs about disclosure22 Jun 2021, 4:26PM Nath Bio-Genes (India) informs about compliance certificate’ 20 Apr 2021, 4:35PM Nath Bio-Genes (India) informs about presentation 12 Feb 2021, 10:36AM Nath Bio-Genes (India) to hold board meeting29 Oct 2020, 12:58PM Nath Bio-Genes (India) informs about virtual meeting22 Sep 2020, 10:47AM Nath Bio-Genes (India) informs about outcome of board meeting15 Jun 2020, 3:34PM Nath Bio-Genes introduces two new cotton hybrids in Indian market28 Apr 2020, 3:14PM

Nath Bio-Genes Stock Price Analysis and Quick Research Report. Is Nath Bio-Genes an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nath Bio-Genes . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nath Bio-Genes has a PE ratio of 9.92937158823377 which is low and comparatively undervalued .

  • Share Price: - The current share price of Nath Bio-Genes is Rs 191.9. One can use valuation calculators of ticker to know if Nath Bio-Genes share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nath Bio-Genes has ROA of 4.58921877924126 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nath Bio-Genes has a Current ratio of 2.40722027932447 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nath Bio-Genes has a ROE of 6.30581115651099 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Nath Bio-Genes has a Debt to Equity ratio of 0.1835 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Nath Bio-Genes has reported revenue growth of 8.23717866966898 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Nath Bio-Genes for the current financial year is 16.2576441751593 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nath Bio-Genes is Rs 2 and the yield is 1.0225 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nath Bio-Genes is Rs 19.3265 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nath Bio-Genes in Ticker for free. Also, one can get the intrinsic value of Nath Bio-Genes by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Nath Bio-Genes
X